Status:

UNKNOWN

Evaluation of the Effects of a Low Free Sugar Diet in Patients With Nonalcoholic Fatty Liver Disease

Lead Sponsor:

National Nutrition and Food Technology Institute

Conditions:

Nonalcoholic Fatty Liver Disease

Eligibility:

All Genders

18-60 years

Phase:

NA

Brief Summary

To study the effects of a low free sugar diet on lipid profile, glycemic indices, liver enzymes, inflammatory factors and hepatic steatosis and fibrosis in patients with Nonalcoholic fatty liver disea...

Eligibility Criteria

Inclusion

  • Age of 18 to 60 years
  • Body Mass Index (BMI) between 25-40
  • Sonographic findings compatible with hepatic steatosis (degree 2 or more)

Exclusion

  • Alcohol consumption
  • pregnancy or lactation
  • Other liver disease (viral,cirrhosis,...)
  • Use of drugs such as phenytoin,tamoxifen,lithium
  • A history of Cancer, autoimmune disease,Renal disease \& Celiac disease, hypothyroidism or Cushing's syndrome
  • Lack of desire to continue studying
  • Have to use antibiotics with hepatotoxic drugs while studying
  • Non-compliance with diet

Key Trial Info

Start Date :

October 23 2019

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

July 21 2020

Estimated Enrollment :

50 Patients enrolled

Trial Details

Trial ID

NCT04369521

Start Date

October 23 2019

End Date

July 21 2020

Last Update

April 30 2020

Active Locations (2)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (2 locations)

1

Azita Hekmatdoost

Tehran, Middle East, Iran, 19835

2

National Nutrition and Food Technology Research Institute

Tehran, Iran

Evaluation of the Effects of a Low Free Sugar Diet in Patients With Nonalcoholic Fatty Liver Disease | DecenTrialz